Skip to content
healthcare.dev

D-133

NDC 58264-0139, Calcium fluoride, Silicon dioxide, Tribasic calcium phosphate, Calcium sulfate anhydrous, Ferrosoferric phosphate, Potassium chloride, Dibasic potassium phosphate, Potassium sulfate, Magnesium phosphate, dibasic trihydrate, Sodium phosphate, dibasic, heptahydrate, Sodium chloride, and Sodium sulfate, solution, from DNA Labs, Inc..

Product NDC
58264-0139
Status
Listed
Labeler
DNA Labs, Inc.
Dosage form
SOLUTION
Route
SUBLINGUAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED HOMEOPATHIC
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/58264-0139 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CALCIUM FLUORIDE8 [hp_X]/mL
  • SILICON DIOXIDE8 [hp_X]/mL
  • TRIBASIC CALCIUM PHOSPHATE6 [hp_X]/mL
  • CALCIUM SULFATE ANHYDROUS6 [hp_X]/mL
  • FERROSOFERRIC PHOSPHATE6 [hp_X]/mL
  • POTASSIUM CHLORIDE6 [hp_X]/mL
  • DIBASIC POTASSIUM PHOSPHATE6 [hp_X]/mL
  • POTASSIUM SULFATE6 [hp_X]/mL
  • MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE6 [hp_X]/mL
  • SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE6 [hp_X]/mL
  • SODIUM CHLORIDE6 [hp_X]/mL
  • SODIUM SULFATE6 [hp_X]/mL

Pharmacologic classes

Blood Coagulation Factor [EPC]; Calcium [CS]; Calculi Dissolution Agent [EPC]; Cations, Divalent [CS]; Increased Coagulation Factor Activity [PE]; Increased Large Intestinal Motility [PE]; Increased Large Intestinal Motility [PE]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]; Magnesium Ion Exchange Activity [MoA]; Osmotic Activity [MoA]; Osmotic Activity [MoA]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Osmotic Laxative [EPC]; Osmotic Laxative [EPC]; Phosphate Binder [EPC]; Phosphate Chelating Activity [MoA]; Potassium Compounds [CS]; Potassium Compounds [CS]; Potassium Salt [EPC]; Potassium Salt [EPC]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]

Package NDCNDC-11Package
58264-0139-15826401390129.57 mL in 1 BOTTLE, GLASS (58264-0139-1)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 58264-0139 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/58264-0139 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 58264-0139. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.